[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
June 1950


Author Affiliations


Arch Ophthalmol. 1950;43(6):1088. doi:10.1001/archopht.1950.00910011105014

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:  —In the April issue of the Archives, under "Correspondence," there was published a letter on "Aureomycin in the Treatment of Virus Diseases," by George A. Sheehan Jr., M.D. Dr. Sheehan reported the local use of aureomycin in a case of "conjunctivitis of supposed Newcastle disease."Aureomycin is undoubtedly a beneficial therapeutic agent in the treatment of virus diseases. However, in January 1950, I had under my care a proved case of Newcastle's conjunctivitis which occurred in a virologist. My associates and I were able to demonstrate inclusion bodies within the epithelial cells both before and after the administration of aureomycin drops, and we found that the drug in no way altered the course of the disease, the presence of which, I repeat, was verified in this case by virologic studies.The inclusion bodies were demonstrable in scrapings, but not in smears, of the conjunctiva, and the disease

First Page Preview View Large
First page PDF preview
First page PDF preview